Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC’s Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports

Public-private partnership to enable the development of innovative, sustainable infrastructure designed to set the global standard for travel biosecurity BOSTON and NEW YORK, Aug. 15, 2022 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA) and XpresSpa Group, Inc. (Nasdaq: XSPA) announced they…